Development of allosteric and selective CDK2 inhibitors for contraception with negative cooperativity to cyclin binding.
Faber EB, Sun L, Tang J, Roberts E, Ganeshkumar S, Wang N, Rasmussen D, Majumdar A, Hirsch LE, John K, Yang A, Khalid H, Hawkinson JE, Levinson NM, Chennathukuzhi V, Harki DA, Schönbrunn E, Georg GI.
Faber EB, et al. Among authors: john k.
Nat Commun. 2023 Jun 3;14(1):3213. doi: 10.1038/s41467-023-38732-x.
Nat Commun. 2023.
PMID: 37270540
Free PMC article.